Cybin (TSE:CYBN) has released an update.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Cybin Inc., a leader in neuropsychiatry treatments, announced that their Chief Medical Officer will participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit. The company specializes in innovative therapies for mental health conditions, including a psilocin program for depression and a DMT program for anxiety that are advancing through clinical trials.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
